PI
CBAY

PEAK6 Investments’s Cymabay Therapeutics CBAY Stock Holding History

PEAK6 Investments’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,006
Closed -$236K – 4910
2023
Q4 		$236K Buy
+10,006
New +$178K ﹤0.01% 3131

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PEAK6 Investments's CBAY Position: Q1 2024 in Review

PEAK6 Investments sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 10,006 shares — an estimated $236K sold.

PEAK6 Investments first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $236K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • PEAK6 Investments reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 10,006 Cymabay Therapeutics shares in Q1 2024, an estimated $236K.
  • PEAK6 Investments first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
  • PEAK6 Investments's Cymabay Therapeutics position peaked at $236K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.